Valuation: DexCom, Inc.

Market Cap 3.39TCr 2.93TCr 2.75TCr 2.5TCr 4.7TCr 3,23900Cr 4.78TCr 32TCr 13TCr 1,62200Cr 13TCr 12TCr 5,38900Cr P/E 2026 *
36x
P/E 2027 * 30.2x
Enterprise Value 3.31TCr 2.86TCr 2.69TCr 2.44TCr 4.59TCr 3,16600Cr 4.67TCr 31TCr 12TCr 1,58500Cr 12TCr 12TCr 5,26800Cr EV / Sales 2026 *
6.33x
EV / Sales 2027 * 5.66x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-0.48%
1 week+2.13%
Current month+7.27%
1 month+16.79%
3 months+37.53%
6 months+27.10%
Current year+34.88%
1 week 87.06
Extreme 87.055
91.96
1 month 69.79
Extreme 69.79
91.96
Current year 56.72
Extreme 56.72
91.96
1 year 54.11
Extreme 54.11
91.96
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
12/08/26 Don

Director

-1,075 0.0003%
12/08/26 Sell

Director

-1,012 0.0003%
03/08/26 Sell

Director

-2,000 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%+2.13%+10.76%-16.97% 3.39TCr
-0.53%+1.61%-15.28%+5.18% 19TCr
+0.21%+1.99%-1.75%+11.80% 12TCr
+0.73%-2.92%+8.67%+75.29% 5.99TCr
-0.92%+0.57%+34.56%+70.98% 5.6TCr
-0.37%+1.73%-6.29%-33.68% 5TCr
-1.62%+3.92% - - 3.14TCr
-1.96%+1.73%-6.04%+27.56% 2.48TCr
-0.28%-0.88%+43.58%-11.16% 2.46TCr
-0.64%-3.52%-5.75%+2.88% 2.27TCr
Average -0.57%+3.04%+6.94%+14.65% 6.13TCr
Weighted average by Cap. -0.36%+3.15%+0.26%+15.62%

Financials

2026 *2027 *
Net sales 523Cr 451.72Cr 424.47Cr 386.04Cr 725.78Cr 50TCr 737.75Cr 4.97TCr 1.94TCr 25TCr 1.96TCr 1.92TCr 83TCr 579.98Cr 500.93Cr 470.72Cr 428.09Cr 804.85Cr 55TCr 818.12Cr 5.52TCr 2.16TCr 28TCr 2.18TCr 2.13TCr 92TCr
Net income 97Cr 84Cr 79Cr 72Cr 135.21Cr 9.32TCr 137.44Cr 926.58Cr 362.28Cr 4.67TCr 365.82Cr 357.88Cr 16TCr 114.89Cr 99Cr 93Cr 85Cr 159.44Cr 11TCr 162.07Cr 1.09TCr 427.2Cr 5.5TCr 431.37Cr 422.01Cr 18TCr
Net Debt -76Cr -66Cr -62Cr -56Cr -105.63Cr -7.28TCr -107.37Cr -723.82Cr -283.01Cr -3.64TCr -285.77Cr -279.57Cr -12TCr -106.15Cr -92Cr -86Cr -78Cr -147.3Cr -10TCr -149.73Cr -1.01TCr -394.68Cr -5.08TCr -398.53Cr -389.88Cr -17TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
17/26/17 $89.62 -0.15% 1,57,406
14/26/14 $89.75 -1.89% 38,58,932
13/26/13 $91.48 +0.75% 46,86,457
12/26/12 $90.80 +1.42% 54,02,528
11/26/11 $89.53 +2.14% 59,71,702
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.75USD
Average target price
94.12USD
Spread / Average Target
+4.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock